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Objectives: Community-acquired (CA) methicillin-resistant Staphylococcus aureus (MRSA) isolates
belonging to clonal complex 80 (CC80) are recognized as the European CA-MRSA. The prevailing Euro-
pean CA-MRSA clone carries a type IVc staphylococcal cassette chromosomemec (SCCmec) and expresses
Panton-Valentine leukocidin (PVL). Recently, a signiﬁcant increase of PVL-negative CC80 MRSA has been
observed in Denmark. The aim of this study was to examine their genetics and epidemiology, and to
compare them to the European CA-MRSA clone in order to understand the emergence of PVL-negative
CC80 MRSA.
Methods: Phylogenetic analysis of the CC80 S. aureus lineage was conducted from whole-genome se-
quences of 217 isolates (23 methicillin-susceptible S. aureus and 194 MRSA) from 22 countries. All iso-
lates were further genetically characterized in regard to resistance determinants and PVL carriage, and
epidemiologic data were obtained for selected isolates.
Results: Phylogenetic analysis revealed the existence of three distinct clades of the CC80 lineage: (a) an
methicillin-susceptible S. aureus clade encompassing Sub-Saharan African isolates (n ¼ 13); (b) a derived
clade encompassing the European CA-MRSA SCCmec-IVc clone (n ¼ 185); and (c) a novel and genetically
distinct clade encompassing MRSA SCCmec-IVa isolates (n ¼ 19). All isolates in the novel clade were PVL
negative, but carried remnant parts (8e12 kb) of the PVL-encoding prophage FSa2 and were susceptible
to fusidic acid and kanamycin/amikacin. Geospatial mapping could link these isolates to regions in the
Middle East, Asia and South Paciﬁc.
Conclusions: This study reports the emergence of a novel CC80 CA-MRSA sublineage, showing that the
CC80 lineage is more diverse than previously assumed. S.M. Edslev, Clin Microbiol Infect 2018;24:273
© 2017 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology
and Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) appeared in
the early 1960s in hospital-associated infections, but from theInstitut, Artillerivej 5, 2300
r Ltd on behalf of European Society
g/licenses/by-nc-nd/4.0/).1990s a global emergence of community-acquired (CA) MRSA in-
fections among healthy people was observed [1e4]. Today, several
genetic lineages of CA-MRSA are present worldwide, with speciﬁc
lineages predominating distinct geographic regions [4e9]. The
clonal complex 80 (CC80) lineage is known as the European CA-
MRSA clone despite its high prevalence both in the Middle East
and Northern Africa [6,10]. The prevailing CC80 MRSA clone ex-
presses the Panton-Valentine leukocidin (PVL) toxin encoded by
the lukS/F-PV genes in the FSa2 prophage and contains a type IVcof Clinical Microbiology and Infectious Diseases. This is an open access article under
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Furthermore, strains belonging to the clone are generically resis-
tant to tetracycline, fusidic acid and aminoglycosides (kanamycin/
amikacin) [5,10e14]. We recently delineated the evolutionary his-
tory of the European CC80 CA-MRSA clone, which suggested that
the origin of the clone was a PVL-positive, methicillin- and fusidic
acidesusceptible ancestral lineage in Sub-Saharan Africa [10]. The
data indicated a single acquisition of an SCCmec-IVc carrying the
kanamycin/amikacin resistance genes (aadK and aphA) and a
plasmid encoding fusidic acid resistance (fusB) during or upon its
dissemination out of this region. Upon acquisition of these ele-
ments, the clone spread rapidly across Northern Africa, the Middle
East and Europe to become the ﬁrst dominant CA-MRSA clone in
these regions.
In the last few years, an increased number of PVL-negative CC80
CA-MRSA isolates has been observed in Denmark, a genotype that
we previously found to be rare [3]. The aim of this study was to
examine the genetics and epidemiology of these PVL-negative CC80
MRSA isolates, and to compare them to the European CA-MRSA
clone in order to understand their emergence.
Methods
Bacterial isolates
The present study included 217 CC80 S. aureus isolates (23
methicillin-susceptible S. aureus (MSSA) and 194MRSA) originating
from four different data sets. First, we included all CC80 MRSA
strains that had been isolated in the capital region of Denmark
between 2013 and 2015 (n ¼ 107), as hospitals here have genome
sequenced all MRSA isolates from 2013 and onwards. Additionally,
all PVL-negative CC80 MRSA isolated between 2008 and 2015
identiﬁed in the Danish national MRSA surveillance register were
included (n ¼ 10). Furthermore, three out of four reported PVL-
negative and SCCmec-IVa-positive CC80 MRSA isolates from
Bangladesh were included [15]. A literature search was performed
to ensure that no other published PVL-negative and SCCmec-IVa-
positive CC80 MRSA isolates were overlooked. Lastly, we included
97 isolates (23 MSSA and 74 MRSA) from our previous European
CA-MRSA study [10]. These isolates were sampled between the
years 1993 and 2010 in Europe, North Africa, Sub-Saharan Africa,
the Middle East and Asia. Only one isolate from each individual was
included.
Clinical and epidemiologic information
Clinical and epidemiologic data were obtained from both pre-
viously published studies [10,15] and the Danish national MRSA
surveillance register (Danish Data Protection Agency protocol
2001-14-0021). The following information was obtained for all
cases: country of origin and year of isolation. For all isolates clus-
tering in the novel clade of CC80, additional clinical and epidemi-
ologic information was extracted: sex, age, ethnicity, family
relations between affected subjects, source of MRSA acquisition
(e.g. imported, household, or hospital related) and whether the
MRSA was related to infection or asymptomatic carriage.
Genome sequencing
Sequence data from the 97 isolates in the fourth data set were
available at the European Nucleotide Archive (ENA; http://www.
ebi.ac.uk/ena, accession number PRJEB6777). Paired-end se-
quences (2  250 or 2  150) for the remaining 120 CC80 isolates
were obtained (MiSeq; Illumina, San Diego, CA, USA). The sequence
data are available at ENA (accession number PREJ19874).Phylogenetic analysis
Single nucleotide polymorphisms (SNPs) in the core genome
were detected using the Northern Arizona SNP Pipeline (NASP;
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320593/) by
aligning Illumina reads against S. aureus 11819-97, a Danish CC80
CA-MRSA isolate (GenBank accession number NC_017351) [16]. The
presence of recombination was investigated using the pairwise
homoplasy index test implemented in SplitsTree v4.13.1 [17].
Genome-wide phylogenetic relationships were reconstructed using
the maximum-likelihood algorithm implemented in PhyML v3.412
[18], using Smart Model Selection with the Bayesian Information
Criterion with 100 bootstrap replicates with nearest neighbour
interchange and subtree priming and grafting searches for optimal
tree structures. The phylogenies were rooted with the community-
associated CC1 strain MW2 (GenBank accession number
BA000033). iTOL (http://itol.embl.de/) was used for visualization of
the phylogenetic tree.
Time of divergence analyses
Coalescence-based analyses were used to investigate the timing
of most recent common ancestor (TMRCA) using BEAST v1.7.5
software (http://beast.bio.ed.ac.uk/) [19]. Evaluation of the models,
which included the general-time reversible and the Hasegawa-
Kishino-Yano substitution models, as well as both strict and
relaxed molecular clock under different demographic models
(Bayesian skyline, constant population and exponentially growing
population tree priors), was performed by Tracer v1.5 (http://tree.
bio.ed.ac.uk/software/tracer/). For each analysis, 200 million steps
were performed, with sampling every 10 000th generation. The
ﬁrst 10% was discarded as burn-in.
Genetic typing and detection of virulence factors
Isolates were spa typed using Sanger sequencing as described
previously [20,21]. Whole-genome sequences were de novo
assembled using CLCbio Genomics Workbench v8.5.1 (Qiagen,
Aarhus, Denmark), and contigs were used for in silico multilocus
sequence typing (MLST) using MLST v1.8 (https://cge.cbs.dtu.dk/
services/MLST/) [22]. Resistance-associated mutations in fusA and
the presence of various resistance genes (e.g. fusB, tet(K) and aadK/
aphA) were identiﬁed in silico. SCCmec elements were identiﬁed
and subtyped in silico by comparison of CC80 MRSA cassettes to
available reference sequences for SCCmec type IVa as previously
described [10]. SNPs in the accessory gene regulator receptor C
gene (agrC) were identiﬁed in all samples using agrC from strain
11819-97 (NC_017351) as reference. Sequences were analysed for
the presence of the PVL-encoding genes lukS/F-PV and the associ-
ated FSa2 prophage using the variant found in strain 11819-97 as a
reference. The genetic diversity of FSa2 prophage and the remnant
parts of FSa2 identiﬁed in this study were examined using NASP
and included reference genomes from ﬁve distinct genetic lineages
of S. aureus as described previously [10].
Results
This study included 217 CC80 S. aureus isolates (23 MSSA and
194 MRSA) sampled between 1993 and 2015 in 22 countries; 146
isolates were collected in Denmark.
Five MLST types were observed among the isolates, with the
majority belonging to sequence type (ST) 80 (n ¼ 210; 97%) and the
remaining being single-locus variants of ST80. Seventeen different
spa types were identiﬁed, with t044 being the most frequent
(n ¼ 138; 64%) (Supplementary Table S1).
S.M. Edslev et al. / Clinical Microbiology and Infection 24 (2018) 273e278 275Phylogenetic relationship of CC80 complex
The isolates were sequenced to a depth of >20 coverage. A
total of 4880 SNPs were identiﬁed within the conserved core
genome (57% of the reference chromosome). Twelve SNPs were
removed as a result of putative recombination events, after which
no statistical signiﬁcant evidence of recombination was identiﬁed
(p 0.4336). The phylogenetic analyses revealed the existence ofFig. 1. Maximum likelihood phylogeny of CC80 Staphylococcus aureus lineage. Phylogeny i
distinct clades of lineage: Sub-Saharan African MSSA clade, European CA-MRSA clade and no
markers includes: carriage of SCCmec type IVa (light blue) or IVc (dark blue), carriage of PVL-
text are bold. CA, community acquired; CC, clonal complex; MRSA, methicillin-resistant
SCCmec, staphylococcal cassette chromosome mec.three distinct clades in the CC80 complex (Fig. 1). One clade
comprised 13 MSSA isolates with strong links to Sub-Saharan Af-
rican countries, a second clade deﬁning the European CA-MRSA
clone comprised 185 isolates (10 MSSA and 175 MRSA) and a
third and novel MRSA clade included 19 CC80 MRSA isolates (three
Bangladeshi ST1931 isolates and 16 Danish ST80 isolates). spa types
of the isolates in the three distinct clades revealed overlap, though
several spa types were unique to speciﬁc clades.s based on 4868 single-nucleotide polymorphisms in core genome and reveals three
vel MSRA clade. Clades are marked with shades of grey. Information on selected genetic
encoding genes lukS/F-PV (purple) and carriage of fusB (green). Isolate IDs referred to in
S. aureus; MSSA, methicillin-susceptible S. aureus; PVL, Panton-Valentine leukocidin;
Table 2
Prevalence of antibiotic resistance genes
Gene n (%) for:
All isolates
(n ¼ 217)
Sub-Saharan
African MSSA
clade (n ¼ 13)
European CA-MRSA
clade (n ¼ 185)
Novel MRSA
clade (n ¼ 19)
mecA 194 (89%) 0 175 (95%) 19 (100%)
fusB 159 (73%) 0 159 (86%) 0
tet(K) 153 (71%) 7 (54%) 143 (77%) 3 (16%)
aadK/aphA 133 (61%) 0 133 (72%) 0
aadK/aphA, kanamycin/amikacin resistance; CA, community acquired; fusB, fusidic
acid resistance; mecA, methicillin resistance; MRSA, methicillin-resistant Staphylo-
coccus aureus; MSSA, methicillin-susceptible S. aureus; tet(K), tetracycline
resistance.
S.M. Edslev et al. / Clinical Microbiology and Infection 24 (2018) 273e278276A Bayesian analysis (Supplementary Fig. S1) revealed that the
TMRCA of the isolates in the Sub-Saharan African MSSA and the Eu-
ropean CA-MRSA clades were dated to 1977 (95% highest posterior
densities (HPDs), 1946e2023) and 1984 (95% HPDs, 1957e2019),
respectively. Eighteen of 19 isolates in the novel MRSA clade were
found to be closely related and formed adistinct clusterwith a TMRCA
estimated to be in 2000 (95% HPDs, 1990e2022). The remaining
isolate,149-den-2013, formed adeepbranchdistant from theother 18
isolates; similar topologies were observed in both the Bayesian and
maximum-likelihood derived analyses (Fig. 1). The TMRCA for the
CC80 lineage was estimated to 1942 (95% HPDs, 1901e2054).
Epidemiologic description of novel MRSA clade
The three ST1931 isolates from Bangladesh were all isolated
from patients with diabetes at one hospital in 2008 and clustered
closely together in the phylogeny with only two SNPs separating
them, thus supporting local transmission. Clinical and demographic
data were available for most of the Danish isolates clustering in the
novel MRSA clade, where a single isolate was isolated in 2009 and
the remaining 15 were isolated between 2013 and 2015 (Table 1).
Nine of the isolates were linked to patients from three different
families and showed close intrafamily clustering (0e20 SNPs). The
epidemiologic data suggested ten unrelated introductions. Seven of
these were related to foreign ethnicity and/or import from coun-
tries in the Middle East, Asia or South Paciﬁc. Twelve of the 19
MRSA isolates were related to infection, with 11 of these being skin
and soft tissue infections, six were related to asymptomatic carriage
and the source of the last isolate was not known (Table 1).
SCCmec identiﬁcation
All MRSA isolates in the European CA-MRSA clade (n ¼ 175) car-
ried a type IVc SCCmec element. Themajority (75%,132/175) of these
contained the aminoglycosides resistance genes aadK (ant(6)-Ia) and
aphA (aph(30)-III), integrated in the J2 region. All 19 MRSA isolates
from the novel MRSA clade carried a type IVa SCCmec. With the
exception of one isolate (149-den-2013), all SCCmec-IVawere largely
identical both in size (26 kb) and genetic content. A 1.9 kb long
transposon in region J1, adjacent to the ccr complex,was identiﬁed in
all SCCmec-IVa cassettes, with the exception of isolate 149-den-2013.Table 1
Clinical and demographic data related to isolates clustering in the novel CC80 PVL-negat
Isolatea MLST Country of isolation Sex Birth year Family rel
98-ban-2008 ST1931 Bangladesh M 1967
99-ban-2008 ST1931 Bangladesh F 2000
100-ban-2008 ST1931 Bangladesh M 1976
103-den-2009 ST80 Denmark F 1983
107-den-2014 ST80 Denmark F 2005
108-den-2015 ST80 Denmark F 1996
115-den-2013 ST80 Denmark F 2006
149-den-2013 ST80 Denmark M 1951
130-den-2015 ST80 Denmark F 1989 1
180-den-2015 ST80 Denmark F 1988 1
184-den-2015 ST80 Denmark F 2015 1
191-den-2015 ST80 Denmark M 1987 1
183-den-2015 ST80 Denmark F 1987 2
186-den-2015 ST80 Denmark M 1982 2
201-den-2015 ST80 Denmark F 1939
202-den-2015 ST80 Denmark M 1984 3
206-den-2015 ST80 Denmark F 2015 3
207-den-2015 ST80 Denmark F 1987 3
205-den-2015 ST80 Denmark M 2014
CC80, clonal complex 80; MLST, multilocus sequence typing; SSTI, skin and soft tissue in
a Each isolate is from an individual person.
b Nine isolates could be linked to three distinct families, designated 1, 2 and 3.Identiﬁcation of PVL genes
All MSSA isolates in the Sub-Saharan AfricanMSSA clade and the
majority (n ¼ 167; 90%) of the isolates in the European CA-MRSA
clade contained the lukS/F-PV genes, whereas none of the isolates
clustering in the novel MRSA clade contained these. However, all of
these isolates carried remnants of the PVL-carrying prophageFSa2,
i.e. between 8 and 12 kb of the full-length FSa2 (58 kb). Similarly,
the PVL-negative isolates in the European CA-MRSA clade also
carried various remnant prophage parts. In all PVL-negative iso-
lates, these were incorporated in the same chromosomal position
as FSa2 in the CC80 reference strain. Investigating the genetic di-
versity of these remnant parts with the remaining CC80 isolates
and otherFSa2-positive CA-MRSA lineages (Supplementary Fig. S2)
conﬁrmed a distinct FSa2-CC80 cluster with only a single SNP
observed within the CC80 cluster, which strongly indicated a single
acquisition of the FSa2 prophage into an ancestral CC80 MSSA
background more than 70 years ago.
Identiﬁcation of antibiotic resistance genes
The prevalence of the trademark CC80 antibiotic resistance
genes (mecA, fusB, tet(K) and aadK/aphA) in the three clades is listed
in Table 2. The fusidic acid resistance gene fusB and kanamycin/
amikacin resistance genes aadK/aphA were identiﬁed in 159 and
133 of the isolates (73% and 61%), respectively, all clustering in theive CA-MRSA clade
ationb Acquisition Ethnicity Infection/carriage
Hospital Bangladeshi SSTI
Hospital Bangladeshi SSTI
Hospital Bangladeshi SSTI
Unknown Danish Unknown
Import (Bangladesh) Burmese SSTI
Import (Asiadunknown country) Danish SSTI
Import (Dubai) Danish SSTI
Import (Philippines) Philippine SSTI
Household Afghani Carriage
Import (Unknown country) Afghani Other infection
Household Afghani SSTI
Household Afghani Carriage
Import (New Zealand) Danish SSTI
Household Danish Carriage
Unknown Danish SSTI
Household Danish SSTI
Household Danish Carriage
Household Danish Carriage
Import (Jordan) Danish Carriage
fection; ST, sequence type.
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clade were fusidic acid resistant due to speciﬁc fusA mutations
(Supplementary Table S1). A total of 153 isolates (71%) carried the
tet(K) gene (tetracycline resistance) encoded on plasmid pT49 or
pT181. The gene was present in isolates in all three clades, with the
highest prevalence in the European CA-MRSA clade.
Discussion
In this study, we have shown that a novel sublineage of CC80
CA-MRSA has been introduced into the capital region of Denmark
within the last few years. This novel sublineage differs from the
typical European CA-MRSA clone not only by its genetic and anti-
microbial susceptibility characteristics (PVL negative, carriage of an
SCCmec-IVa element and susceptibility to fusidic acid and amino-
glycosides) but also by its unique phylogenetic clustering. Thus,
these results add a new chapter to the evolutionary history of the
CC80 lineage.
Although all isolates in the novelMRSA cladewere PVL negative,
this cannot be used as a reliable marker, as several isolates in the
European CA-MRSA clade (n ¼ 18; 10%) lacked PVL. In fact, during
the last few years, there has been an increase in PVL-negative CC80
MRSA strains in Denmark. Whereas none of the tested (n ¼ 119)
CC80 MRSA strains submitted to the Danish National MRSA sur-
veillance laboratory between 1999 and 2006 (n ¼ 418) were PVL
negative, 18% (36/202) of all CC80 strains submitted between 2013
and 2015 were PVL negative (data not shown). PVL-negative CC80
MRSA strains have also been reported in other countries, where this
clone is endemic [14].
All PVL-negative isolates in this study carried remnants of pro-
phage FSa2, indicating that they have derived from a PVL-positive
ancestor that, during evolution, lost part of the phage, including the
lukS/F-PV genes. Our results suggest that multiple independent
losses must have occurred in the CC80 lineage, as multiple FSa2
remnants variants were identiﬁed and PVL-negative isolates in the
European CA-MRSA clade occurred sporadically across the phy-
logeny (Fig. 1). The rise in clinical cases of PVL-negative CC80 MRSA
supports that PVL is not an essential genetic trait associated with
the success of the clone, at least nowadays. A nonsynonymous agrC
SNP (L184I) was one of four unique SNPs described to distinguish
the European CA-MRSA clade from the Sub-Saharan African MSSA
clade [10]. All isolates from the novel clade contained the same
variant (184L) as the Sub-Saharan African isolates (data not shown).
Analysis of the SCCmec revealed that different type IV elements
have been introduced into the CC80 lineage, with SCCmec-IVc
exclusively associated with the European CA-MRSA clone and
SCCmec-IVa in the novel MRSA clade. It is likely that SCCmec-IVa
elements were introduced into the lineage twice, as one of the
isolates in the novel clade (isolate 149-den-2013) formed a long,
deep branch (Fig. 1) and carried a slightly different variant
of SCCmec-IVa that lacked a transposable element in J1. If the
SCCmec-IVa only were introduced ones back in the late-1940s
(Supplementary Fig. S1) and thus precede the emergences of
SCCmec type IV by decades [10], this would change the history of
SCCmec considerably [23].
The MRSA isolates in the novel clade also differed from the
European CA-MRSA by being susceptible to both fusidic acid and
aminoglycosides (Table 2).
Thirteen (68%) of the 19 isolates in the novel MRSA clade were
linked to countries in the Middle East, Asia or the South Paciﬁc by
recent travel and/or foreign ethnicity (Table 1).
A limitation of the present study is that the majority of the
isolates in the novel clade are from Denmark, as reports of CC80
MRSAwith the genotypic characteristics presented here are limited
[15]. Additional investigations on the presence and prevalence ofthis subtype in the Middle East, Asia and the South Paciﬁc are
therefore necessary in order to validate this link. In addition,
identiﬁcation and geographic knowledge of MSSA isolates basal to
the novel MRSA clade would be important for the determination of
a geographical origin of the CC80 lineage.
In summary, we here describe the presence of a novel PVL-
negative SCCmec-IVa CC80 MRSA clone in Denmark, but with the
mobility of people both regionally and internationally, there is
certainly an opportunity for this clone to have disseminated to
other geographic regions. Our results highlight the usefulness of
routine surveillance of MRSA using next-generation sequencing
combined with detailed bioinformatic analysis to further under-
stand population dynamics and emergence of novel lineages.
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